|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1418083631 |
| 003 |
DE-627 |
| 005 |
20240503210404.0 |
| 007 |
tu |
| 008 |
110801s2011 xx ||||| m 00| ||ger c |
| 035 |
|
|
|a (DE-627)1418083631
|
| 035 |
|
|
|a (DE-576)348083637
|
| 035 |
|
|
|a (DE-599)BSZ348083637
|
| 035 |
|
|
|a (OCoLC)753060415
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a ger
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Rybol, Philip
|d 1981-
|0 (DE-588)1014274729
|0 (DE-627)666270465
|0 (DE-576)348083238
|4 aut
|
| 245 |
1 |
0 |
|a Evaluation eines Cocktails aus 5 Arzneimitteln zur Phänotypisierung von CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, NAT-2 und Xanthinoxidase
|c vorgelegt von Philip Rybol
|
| 264 |
|
1 |
|c 2011
|
| 300 |
|
|
|a 78 Bl.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|a Heidelberg, Univ., Diss., 2011
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f DISS
|x XA-DE-BW
|2 pdager
|5 DE-16
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 856 |
4 |
2 |
|u http://d-nb.info/1014274842/04
|m B:DE-101
|q application/pdf
|3 Inhaltsverzeichnis
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20150418
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2011
|
| 998 |
|
|
|g 1014274729
|a Rybol, Philip
|m 1014274729:Rybol, Philip
|d 50000
|d 51001
|e 50000PR1014274729
|e 51001PR1014274729
|k 0/50000/
|k 1/50000/51001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1418083631
|e 2839920387
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"physDesc":[{"noteIll":"graph. Darst.","extent":"78 Bl."}],"type":{"bibl":"thesis"},"language":["ger"],"recId":"1418083631","origin":[{"dateIssuedDisp":"2011","dateIssuedKey":"2011"}],"title":[{"title":"Evaluation eines Cocktails aus 5 Arzneimitteln zur Phänotypisierung von CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, NAT-2 und Xanthinoxidase","title_sort":"Evaluation eines Cocktails aus 5 Arzneimitteln zur Phänotypisierung von CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, NAT-2 und Xanthinoxidase"}],"id":{"eki":["1418083631"]},"noteThesis":["Heidelberg, Univ., Diss., 2011"],"name":{"displayForm":["vorgelegt von Philip Rybol"]},"person":[{"role":"aut","display":"Rybol, Philip","given":"Philip","family":"Rybol"}]}
|
| SRT |
|
|
|a RYBOLPHILIEVALUATION2011
|
